| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2008 Jun; 30(5):383-408.
Abstract | Full Citation |
| Nakamoto H, Imai H, Fukushima R, et al.
Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis. [Journal Article]
Perit Dial Int 2008 Jun.:S83-7.
Abstract | Full Citation |
| Suwannakul S, Ieiri I, Kimura M, et al.
Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism. [JOURNAL ARTICLE]
J Hum Genet 2008 Jul 19.
Abstract | Full Citation | Find Related Articles |
| Neutel JM
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Jul 9.
Abstract | Full Citation | Find Related Articles |
| Tanaka H, Nagasawa Y, Matsui I, et al.
Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics. [JOURNAL ARTICLE]
Clin Exp Nephrol 2008 Jun 24.
Abstract | Full Citation |
| Scott LJ, McCormack PL
Olmesartan medoxomil : a review of its use in the management of hypertension. [Journal Article]
Drugs 2008; 68(9):1239-72.
Abstract | Full Citation |
| Smith DH
Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension. [Journal Article]
Drugs 2008; 68(9):1207-25.
Abstract | Full Citation |
| Kurita S, Takamura T, Ota T, et al.
Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects. [JOURNAL ARTICLE]
Eur J Pharmacol 2008 Apr 16.
Abstract | Full Citation | Find Related Articles |
| Waseda Y, Yasui M, Nishizawa Y, et al.
Angiotensin II Type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice. [JOURNAL ARTICLE]
Respir Res 2008 May 23; 9(1):43.
Abstract | Full Citation | Find Related Articles |
| Chrysant SG, Melino M, Karki S, et al.
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. [Journal Article]
Clin Ther 2008 Apr; 30(4):587-604.
Abstract | Full Citation | Find Related Articles |
  |
